Ready to play
Ready to play
The article discusses the development of asthma management through advances in treatments and technologies, with a focus on shifting from reactive-based therapy to prevention and continuous control. It explains that over-reliance on rescue inhalers, such as salbutamol, is problematic because they only treat symptoms and do not reduce the chronic inflammation in the airways, which increases the risks of attacks and earlier mortality. Conversely, new strategies have been introduced, including combined maintenance and relief therapies, anti-inflammatory treatment during attacks, and biological drugs for severe cases. These approaches help control inflammation and reduce dependence on long-term oral steroids, which can be harmful. Modern care relies on smart technologies such as inhaler devices equipped with sensors and smartphone apps that monitor usage and alert patients to errors or changes. Additionally, AI-powered weather alerts notify patients of asthma attack risks based on weather conditions and pollutants. The goal is to make asthma a fully controllable disease, improving the lives of millions of patients and significantly reducing their attacks.
Notice: This Is an AI-Generated Summary
Comments (0)